First Trust Advisors’s Vanda Pharmaceuticals VNDA Stock Holding History

First Trust Advisors’s Portfolio VNDA Stock Details VNDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-84,967	Closed	-$926K	–	2616
2022 Q2	$926K	Sell	84,967 -896	-1%	-$9.28K	﹤0.01%	2015
2022 Q1	$971K	Sell	85,863 -4,957	-5%	-$65.2K	﹤0.01%	2051
2021 Q4	$1.43M	Buy	90,820 +10,525	+13%	+$183K	﹤0.01%	1924
2021 Q3	$1.38M	Buy	+80,295	New	+$1.41M	﹤0.01%	1919
2019 Q2	–	Sell	-128,598	Closed	-$2.37M	–	2510
2019 Q1	$2.37M	Buy	128,598 +22,724	+21%	+$518K	﹤0.01%	1453
2018 Q4	$2.77M	Buy	+105,874	New	+$2.49M	0.01%	1290
2017 Q4	–	Sell	-69,942	Closed	-$1.25M	–	2466
2017 Q3	$1.25M	Buy	69,942 +157	+0.2%	+$2.63K	﹤0.01%	1749
2017 Q2	$1.14M	Buy	+69,785	New	+$1.01M	﹤0.01%	1790

Other funds holding VNDA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

First Trust Advisors's VNDA Position: Q3 2022 in Review

First Trust Advisors sold out of Vanda Pharmaceuticals (VNDA) in Q3 2022, closing a stake of 84,967 shares — an estimated $926K sold.

First Trust Advisors first reported a position in VNDA in Q2 2017 and held it in 8 quarters. The position peaked at $2.77M in Q4 2018. 178 funds tracked by Wall St. Rank hold VNDA as of Q3 2022.

First Trust Advisors reported no remaining Vanda Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
First Trust Advisors sold 84,967 Vanda Pharmaceuticals shares in Q3 2022, an estimated $926K.
First Trust Advisors first reported a position in Vanda Pharmaceuticals in Q2 2017 and held it in 8 quarters.
First Trust Advisors's Vanda Pharmaceuticals position peaked at $2.77M in Q4 2018.
178 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q3 2022.

Based on First Trust Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.